We have applied a computational strategy, based on the synergy of virtual screening, docking and molecular dynamics techniques, aimed at identifying possible lead compounds for the non-covalent inhibition of the main protease 3CL pro of the SARS-Cov2 Coronavirus. Based on the recently resolved 6LU7 PDB structure, ligands were generated using a multimodal structure-based design and then optimally docked to the 6LU7 monomer. Docking calculations show that ligand-binding is strikingly similar in SARS-CoV and SARS-CoV2 main proteases, irrespectively of the protonation state of the catalytic CYS-HIS dyad. The most potent docked ligands are found to share a common binding pattern with aromatic moieties connected by rotatable bonds in a pseudo-linear arrangement. Molecular dynamics calculations fully confirm the stability in the 3CL pro binding pocket of most potent binder identified by docking, namely a chlorophenyl-pyridyl-carboxamide derivative. At the beginning of this year, the world was dismayed by the outbreak of a new severe viral acute respiratory syndrome (SARS), currently known as COVID-19, that rapidly spreads 1 arXiv:2002.09937v1 [q-bio.BM] 23 Feb 2020 from its origin in the Hubei Chinese district to virtually whole China and, as of today, to more than twenty nations in five continents. 1 The new coronavirus, named SARS-CoV2 and believed to have a zoonotic origin from the "wet markets" of the Chinese city Wuhan, has infected thus far about 80000 people worldwide with nearly 13000 in critical conditions, causing the death of more than 2000 people. SARS-CoV2 belongs to the family of the Coronaviridae and, as such, its genome 2,3 has a large identity, from 80% to 96%, 4 with that of the SARS-CoV whose epidemic started in early in 2003 and ended in the summer of the same year. Most of the Coronaviridae genome encodes two large polyproteins, pp1a and, through ribosomal frameshifting during translation, 5 pp1ab. These polyproteins are cleaved and transformed in mature non-structural proteins (NSPs) by the two proteases 3CL pro (3Clike protease) and PL pro (Papain Like Protease) encoded by the open reading frame 1. 6 NSPs, in turn, play a fundamental role in the transcription/replication during the infection. 5
coronavirus activity immediately after the SARS outbreak, 12 no anti-viral drug was ever approved or even reached the clinical stage due to a sharp decline in funding of coronavirus research after [2005] [2006] , based on the patently erroneous conviction by policy-makers and scientists that chance of a repetition of a new zoonotic transmission was extremely unlikely.
The most potent non-covalent inhibitor for 3CL pro , ML188, was actually reported nearly ten years ago 13 with moderate activity in the low micromolar range. 14 Development of SMC targeting 3CL pro can hence be restarted from SARS experience, by exploiting the large level of homology between SARS-CoV and SARS-CoV2 3CL pro . According to the latest report of the structure of 3CL pro from SARS-CoV2 15 (PDB code 6LU7) and the available structure of 3CL pro from SARS-CoV, 12 (PDB code 1UK4), the two main proteases differ by only 12 amino acids, with α carbon atoms all lying at least 1 nm away from the 3CL pro active site (see Figure 1a ). The substrate-binding pockets (shown as a surface representation) of two Figure 1b , exhibiting a strikingly high level of alignment of the key residues involved in substrate binding, including the CYS145· · · HIS41 dyad, and HIS163/HIS172. The latter residues, along with GLU166, are believed to provide the opening gate for the substrate in the active state of the protomer. 12 Figure 1 (a,b) strongly suggest that effective non-covalent inhibitors for SARS-CoV and SARS-CoV2 main proteases should share the same structural and chemical features. In order to investigate this matter, we have performed a molecular modeling study on both the 6LU7 and 1UK4 PDB structures using a molecular docking approach. 6LU7 is the monomer of the main protease in the active state with the N3 peptidomimetic inhibitor 15 while 1UK4 is the dimer with the protomer chain A in the active state. 12 The main protease monomer contains three domains. Domains I and II (residues 8-101 and residues 102-184) are made of antiparallel β-barrel structures in a chymotrypsin-like fold responsible for catalysis. The substrate-binding site is located in a cleft between these two domains. 16
The 6LU7 structure was first fed to the PlayMolecule web application by Acellera 17 (www.playmolecule.org) using a novel and effective virtual screening technique for the multimodal structure-based ligand design, 18 called Ligand Generative Adversarial Network (LIGANN). Ligands in LIGANN are generated so as to match the shape and chemical attributes of the binding pocket and decoded into a sequence of SMILES enabling directly the structure-based de novo drug design. SMILES code for optimally shaped ligands were obtained using the default LIGANN values for shapes and channels with the cubic box center set at the midpoint vector connecting the SH and NE atoms of the CYS-HIS dyad in the 6LU7 crystallographic structure of SARS-CoV2 main protease monomer in the active state.
The PlayMolecule interface delivered 93 optimally fit non-congeneric compounds, spanning a significant portion of the chemical space, whose SMILES and structures are reported in the Supporting Information. Each of these compounds was docked to the 6LU7 and to the 1UK4 (monomer, chain A) structures, using Autodock4. 19 For both structures, the docking was repeated by setting the dyad with the residue in their neutral (CYS-HIS) and charged state (CYS − /HIS + ). The searching box for optimal docking was again approximately centered at the CYS-HIS dyad and full ligand flexibility was assumed. The minimum search was done using 50 cycles of Lamarckian Genetic Algorithm and empirical free energy scoring function with Babel-generated 20 Gesteiger atomic charges. Further details on Docking parameters are given in the Supporting Information.
Results for the binding free energies of the 93 LIGGAN-determined 3CL pro ligands are reported in Figure 2 . Binding free energies are comprised in the range 4-9 kcal/mol and are found to be strongly correlated for the two protonation states of the CYS-HIS dyad, hence indicating a weak dependency of the inhibition potency on pH in the range 6-8. Correlation is still quite high when ligand binding free energies for the main proteases are compared, confirming that good binders for SARS-CoV are, in general, also good binders for SARS-CoV2 3CL pro . Table 1 of the Supporting Information. The common color-coded z-scale on the right corresponds to the 2D probability.
For each of these compounds, using the knowledge-based XLOGP3 methodology, 21 we computed the octanol/water partition coefficient (LogP) to assess the distribution in hydrophobic and cytosolic environments. Computed LogP values range from -0.5 to a max-imum of 5 with a number of rotatable bonds from 2 to a maximum of 12. Most of the LIGGAN compounds bear from 2 to 5 H-bond acceptor or donors. Values of ∆G and LogP for each of the 93 compounds are reported in Table 1 of the Supporting Information. In Table   1 , the binding free energy data of these five best ligands are shown for both CoV proteases and both protonation states of the catalytic dyad. As previously inferred based on 3CL pro similarities (see Figure 1 ), inspection of Table 1 confirms that SARS-CoV2 best binders 27, 29, 39, 77, 19 are also good binders for SARS-CoV 3CL pro . Remarkably, compound 27 is consistently the most potent ligand for the two proteases, irrespectively of the dyad protonation state. In the Table 1 we also report the Autodock4-computed binding free energy for ML188. The Autodock4-predicted binding free energy for the association of ML188-SARS- Cov protease is -6.2 and -6.5 kcal/mol for the H-HIS and H-CYS tautomers, not too distant indeed from the experimentally determined value of -8 kcal/mol, hence lending support for the LIGGAN-Autodock4 protocol used in identifying the lead compounds of Table 1 . In order to assess the stability of the 3CL pro -27 association, we have performed extensive molecular dynamics simulations of the ligand-protein bound state with explicit solvent, using the GROMACS program. 2, 3 The overall structural information was obtained by combining data from three independent simulations (for a total of about 120 ns), all started from the best docking pose of 27 on the 6LU7 monomeric structure with a different seed for initial velocity randomization. These simulations are performed following a state-of-theart technical protocol extensively described in Ref. 26 Further methodological aspects are provided in the Supporting Information. In Figure 5 , we show the probability distribution, V site of few Å 3 at most. 27 The MD-determined P (R) neatly shows that the ligand never leaves the binding pocket of the chymotripsyn-like fold at any stage during the whole simulation.
In the inset of Figure 5a we show the potential of mean force (PMF) along the intermolecular 28 the steepness of the curve is suggestive of a profound minimum with respect to the zero in the bulk at large R and hence of a large association constant, fully confirming the indication obtained from the Docking calculations. In Figure 5b we show all polar and hydrophobic residues found in at least 90% of the simulation time within 4.5 and 5.5 Å distance, respectively, from any atom of the ligand 27. Basically all putative essential residues for binding (see Figure 1 ) are included, with the important addition of Met165, Phe140 and Leu141 hydrophobic residues that consistently linger near the pyrazolic or the chlorinated phenyl rings of 27, in agreement with the hydrophobic character of the interaction.
To the light of these encouraging preliminary results, in the near future, in order to single out the optimal lead compound for 3CL pro inhibition, we are planning to perform absolute binding free energies on the most potent LIGGAN-Autodock4 binders using fast switching double annihilation non-equilibrium technique as described in Ref. 29, 30 On the other hand, Figures 3 and 5 shows possible avenues for improvement. For example, forcing the L-shaped binding structure (see Figure 5b ) in bulk also, possibly by redesigning the rotatable connectors in the ligand, may reduce the penalty due conformational entropy loss upon binding, 27 hence boosting the ligand affinity for 3CL pro . Building upon this knowledge, we hence plan to optimize the lead using MD simulations coupled to efficient relative binding free energy calculation via free energy perturbation on congeneric variants, 31 eventually providing in silico determined anti-viral compounds to be synthesized an experimentally tested in vitro and in vivo.
We finally note that the infection rate for COV19 is currently declining for days. As the road for delivering an effective anti-viral drug is still a long one indeed, the SARS-Cov2 harsh lesson, nonetheless, should not be forgotten once the emergency will end, hoping that our contribution can pave the way for the design of effective non-covalent antiviral drugs for the present and future Coronavirus emergencies.
(2) 2020; Viralzone News, https://viralzone.expasy.org. Figure S1: 2D-structures for compounds 1 to 20. In box one of the best five binders. 
Computational Details

Molecular Docking
Following the two input file used for molecular docking. 
Molecular Dynamics Simulations
Molecular dynamics (MD) simulations were carried out in a cubic box with periodic boundary conditions, whose side-length was chosen so that the minimum distance between protein atoms belonging to neighboring replicas was larger than 14 Å in any direction. The system (protein+compound) was explicitly solvated with the SPC/E 1 water model at the standard density. The starting configuration was generated using GROMACS 2,3 and PrimadORAC. 4 The system was initially minimized at 0 K with a steepest descent procedure and subsequently heated to 298.15 K in an NPT ensemble (P=1 atm) using Berendsen barostat 5 and velocity rescaling algorithm 6 with an integration time step of 0.1 fs and a coupling constant of 0.1 ps for 250 ps.
Production run in the NPT ensemble were carried out starting three independent simulations with different initial velocities randomization. Each MD run has been performed for 40 ns (for a total of 120 ns) imposing rigid constraints only on the X-H bonds (with X being any heavy atom) by means of the LINCS algorithm (δt=2.0 fs). 7 Electrostatic interactions were treated by using particle-mesh Ewald (PME) 8 method with a grid spacing of 
